WeVote

Bill

Bill

S 2374

Prohibits pre-approval or precertification of cancer treatments, tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.

2026-2027 Regular Session Introduced by Jon Bramnick and 1 co-sponsor

New Jersey bill eliminates insurance pre-approval requirements for cancer treatments and drugs, enabling immediate access but potentially raising premiums and allowing denied claims post-treatment.

Introduced in the Senate, Referred to Senate Commerce Committee
0
WeVote Research Nonpartisan
Bill Summary · S 2374

Legislative bill overview

S 2374 would prohibit health insurance plans from requiring pre-approval or precertification before covering cancer treatments, tests, procedures, and prescription drugs. This means patients and their oncologists could access these cancer-related services immediately without waiting for insurance company authorization, though insurers would retain post-treatment review rights.

Why is this important

Cancer treatment often requires time-sensitive decisions where delays can significantly impact outcomes. Eliminating precertification requirements could reduce treatment delays and administrative burden for patients and providers, though it may increase insurers' costs and potentially affect premium pricing. The bill addresses a real frustration in cancer care where authorization delays can be dangerous.

Potential points of contention

  • Cost implications: Removing precertification gatekeeping could increase insurance claims and premiums, as there's no upfront cost control mechanism; insurers and employers may resist higher expenses
  • Scope and definition: "Cancer-related" services are broadly defined, potentially including treatments of questionable necessity or experimental therapies that precertification currently screens
  • Unintended consequences: Post-treatment review alone may not prevent inappropriate or duplicative services, and patients might face surprise denials and bills after treatment completion rather than before

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.